AzTrials
AzTrials

Disorder of ConsciousnessCTPDOCNCT05558930

Cerebellar iTBS in Patients With Disorders of Consciousness

A study testing iTBS stimulation in people with Disorder of Consciousness and Vegetative State, run by Xijing Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex.Investigator evaluate the effects of bilateral cerebellar TMS on Coma Recovery Scale-Revised (CRS-R) scores in patients with disorders of consciousness(DOC) in a randomized, double-blinded… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
iTBS stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
44 participants
Where
1 siteChina
Study dates
29 Apr 2022to Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • VS/UWS or MCS according to diagnostic criteria
  • Age ≥18 years
  • Written informed consent obtained

Who cannot join

  • Patients in coma
  • Brain injury <1week
  • Presence of metallic hardware in close contact to the discharging coil(such as cochlear implants, or an Internal Pulse Generator or medication pumps)
  • Patients with high risks according to standard questionnaire to screen transcranial magnetic stimulation(TMS) candidates

Trial locations and contacts

1 site in 1 country.

Wen Jiang contact

China1 site, 1 recruiting
  • Xijing hospital, Air Force Military Medical University

    Xi'an, Shaanxi, 710032

    Rong Chen, 18292575563, cmuchenrong@126.com

    Recruiting

Other trials in China

About this study

Official title: MRI-navigated Cerebellar Intermittent Theta-Burst Stimulation(iTBS)in Patients With Disorders of Consciousness

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex.Investigator evaluate the effects of bilateral cerebellar TMS on Coma Recovery Scale-Revised (CRS-R) scores in patients with disorders of consciousness(DOC) in a randomized, double-blinded, sham-controlled, crossover experimental design.

Read the detailed description

Patients with disorders of consciousness(DOC) resulting from severe brain injury greatly burden caregivers, health care facilities, and society. However, there is no definitively effective treatment for patients with DOC.

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex through the dentato-rubro-thalamic tract. Investigators aim to validate the effect of 5 consecutive sessions of intermittent theta-burst stimulation(iTBS) of bilateral cerebellar on level of consciousness of patients in vegetative state(VS)/unresponsive awakening state(UWS)or minimally conscious (MCS) state in a randomized, double-blinded, sham-controlled, crossover study.

TMS is a non-invasive and safe neural regulatory approach that is widely used in depression, schizophrenia, stroke, and Parkinson's disease.

Being tested
iTBS stimulation, sham stimulation
Keywords
TMS, cerebellar, iTBS, DOC, MCS, VS
Medical subject headings
Consciousness Disorders, Persistent Vegetative State

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iTBS stimulationDevice

    standard iTBS burst pattern:3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals. 600 pulses on both side of cerebellar with an interval of 5 minutes.

  • sham stimulationDevice

    Participants receive a sound stimulation with the same pattern with iTBS stimulation,but without magnetic field

Study groups in NCT05558930
Study groupRoleWhat they receive
iTBS stimulationExperimentalParticipants receive iTBS stimulation of bilateral cerebellar one session per day for 5 consecutive days.
Receives: Device: iTBS stimulation
sham stimulationSham comparatorParticipants receive sham stimulation of bilateral cerebellar one session per day for 5 consecutive days.
Receives: Device: sham stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in CRS-R Total Scores

    Whether bilateral cerebellar iTBS would improve consciousness in enrolled patients. CRS-R total score is used to measure level of consciousness of disorder.The coma recovery scale-revised(CRS-R) consists of six subscales addressing auditory, visual, motor, verbal, communication, and arousal functions.The lowest item on each subscale represents reflexive activity and the highest item represents cognitively mediated behavior. Maximum scores of each subscale are summed to obtain the total score (from 0 to 23).The score for each subscale is based on the presence or absence of a specific behavioral response to a sensory stimulus (higher scores are better).

    Measured: Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)

Secondary outcomes (3)
  1. Change in CRS-R Subscale Scores

    The coma recovery scale-revised(CRS-R) consists of six subscales addressing auditory, visual, motor, verbal, communication, and arousal functions.The lowest item on each subscale represents reflexive activity and the highest item represents cognitively mediated behavior. The score for each subscale is based on the presence or absence of a specific behavioral response to a sensory stimulus (higher scores are better).

    Measured: Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)

  2. Change of Influence on EEG

    EEG will be monitored on the first and fifth sessions of both iTBS and sham stimulation, from 20 minutes before the start of stimulation until 30 minutes after the end of stimulation.

    Measured: Baseline and after 5 sessions of iTBS and sham stimulation(5 days)

  3. Influence of time since insult on the results

    Glasgow Outcome Scale-Extended(GOSE) score will be assessed at 3 and 6 months of enrollment.

    Measured: Participants will be followed for the duration of 0.5 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2022
  2. Study start29 Apr 2022
  3. Primary completionApr 2023 (estimated)
  4. Study completionOct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
A randomized double-blinded, sham-controlled, crossover study design is used to investigate the effects of bilateral cerebellar iTBS on patients with prolonged DOC in a VS/UWS or in a MCS state. We prospectively recruit 44 patients in VS/UWS or MCS state. Each patient will receive bilateral cerebellar iTBS and sham stimulation in random order, one session per day for 5 consecutive days, separated by a 5-day washout. TMS is performed by personalized neuro-navigation to target the cerebellar dentate nucleus. The primary research outcome is whether bilateral cerebellar iTBS, as compared to sham stimulation, will improve consciousness (as measured by changes in CRS-R total scores) in VS/UWS and MCS patients. Secondary research outcome is evaluated by Electroencephalogram(EEG), CRS-R subscore, and Glasgow Outcome Scale-Extended(GOSE) score at 3 and 6 months of enrollment.
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
44 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05558930
Sponsor's protocol ID
20222028
Acronym
CTPDOC
Status last verified
May 2022
First submitted
1 Sep 2022
Last updated
28 Sep 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing iTBS stimulation in people with Disorder of Consciousness and Vegetative State, run by Xijing Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rong Chen (18292575563, cmuchenrong@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in CRS-R Total Scores (time frame: Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2022; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in